Latest filing published 03 Dec 2019 for Promore Pharma, €1,407.
Insider track record
Jenni Fredrika Björnulfson: trading record in brief
All filings by Jenni Fredrika Björnulfson on record concern Promore Pharma. In total, 4 filings cover trades dated from 6 July 2017 to 29 November 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 3 December 2019 with a transaction (€1,407) in Promore Pharma. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Jenni Fredrika Björnulfson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ SEK 3.7125.3% of flowBTA (betald tecknad aktie)ISIN SE0009947740FI:csv-4c48ab3dc750cb28ae46
- 1,500 shares@ SEK 3.719.5% of flowAktieISIN SE0009947740FI:csv-349c9c591d5d06ecbec7
- 3,000 shares0ISIN SE0009997158FI:csv-51f7d6d1da160f28fccc
- 1,500 shares@ SEK 23.3065.2% of flowISIN SE0009947740FI:csv-979b2430ae6c27c4edbf
4 of 4 declarations